IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q4 2018 Holdings

Filed 2019-02-14 | 8 holdings | $56.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Axogen Inc(AXGN)COM05463X106$56.0M2,739,75199.7%
Revance Therapeutics Inc(RVNCEUR)COM761330109$91.7K3,342,0470.2%
EyepointCOM74440J101$79.2K41,903,9560.1%
Medicinova Inc(MNOV)COM58468P206$14.6K1,170,3700.0%
Endologix IncCOM29266S106$5.4K1,257,4680.0%
CoriumCOM21887L107$3.4K00.0%
CatalystCOM14888D109$62578,6220.0%
Acura Pharmaceuticals Inc(ACUR)COM00509L802$2151,956,3970.0%